New data set reveals Asian American breast cancer survival advantage persists despite reproductive, lifestyle, neighborhood, and treatment factors, highlighting crucial ethnic and nativity differences.
Scarlett Lin Gomez, PhD, MPH
Advertisement
Articles by Scarlett Lin Gomez, PhD, MPH
UCSF's Scarlett Lin Gomez, PhD, MPH, discusses how the clinician-researcher partnership shapes future work.
Scarlett Lin Gomez, PhD, MPH, of UCSF, explains why Asian American women's breast cancer survival advantage persists after adjusting for clinical and lifestyle factors.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Denosumab Biosimilar Approved For Existing Oncology Indications
2
Plinabulin Receives FDA Fast Track Designation in Post-ICI NSCLC
3
FDA Oncology Recap: Approvals, Designations, and Decisions in September 2026
4
Giredestrant Plus Everolimus Improves PFS in ER+ Advanced Breast Cancer
5